JP5932786B2 - カンジダ症の予防のための組成物 - Google Patents
カンジダ症の予防のための組成物 Download PDFInfo
- Publication number
- JP5932786B2 JP5932786B2 JP2013518309A JP2013518309A JP5932786B2 JP 5932786 B2 JP5932786 B2 JP 5932786B2 JP 2013518309 A JP2013518309 A JP 2013518309A JP 2013518309 A JP2013518309 A JP 2013518309A JP 5932786 B2 JP5932786 B2 JP 5932786B2
- Authority
- JP
- Japan
- Prior art keywords
- composition
- sodium
- group
- composition according
- potassium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims description 86
- 241000222122 Candida albicans Species 0.000 title claims description 22
- 206010007134 Candida infections Diseases 0.000 title claims description 13
- 201000003984 candidiasis Diseases 0.000 title claims description 13
- 230000002265 prevention Effects 0.000 title claims description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 21
- 239000000126 substance Substances 0.000 claims description 21
- 239000000606 toothpaste Substances 0.000 claims description 21
- 229940034610 toothpaste Drugs 0.000 claims description 20
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 17
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 17
- 239000000811 xylitol Substances 0.000 claims description 17
- 235000010447 xylitol Nutrition 0.000 claims description 17
- 229960002675 xylitol Drugs 0.000 claims description 17
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 230000003449 preventive effect Effects 0.000 claims description 14
- 239000006071 cream Substances 0.000 claims description 13
- 239000004615 ingredient Substances 0.000 claims description 13
- 239000004094 surface-active agent Substances 0.000 claims description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 9
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 claims description 8
- 239000008271 cosmetic emulsion Substances 0.000 claims description 8
- 239000003205 fragrance Substances 0.000 claims description 8
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims description 8
- 239000003755 preservative agent Substances 0.000 claims description 8
- 230000002335 preservative effect Effects 0.000 claims description 8
- 239000002304 perfume Substances 0.000 claims description 7
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 208000002925 dental caries Diseases 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 claims description 6
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 5
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 5
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 5
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical group [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 5
- 235000003599 food sweetener Nutrition 0.000 claims description 5
- 235000010408 potassium alginate Nutrition 0.000 claims description 5
- 239000000737 potassium alginate Substances 0.000 claims description 5
- MZYRDLHIWXQJCQ-YZOKENDUSA-L potassium alginate Chemical compound [K+].[K+].O1[C@@H](C([O-])=O)[C@@H](OC)[C@H](O)[C@H](O)[C@@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@@H](O)[C@H]1O MZYRDLHIWXQJCQ-YZOKENDUSA-L 0.000 claims description 5
- 235000010413 sodium alginate Nutrition 0.000 claims description 5
- 239000000661 sodium alginate Substances 0.000 claims description 5
- 229940005550 sodium alginate Drugs 0.000 claims description 5
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims description 5
- 239000000600 sorbitol Substances 0.000 claims description 5
- 235000010356 sorbitol Nutrition 0.000 claims description 5
- 239000003765 sweetening agent Substances 0.000 claims description 5
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 4
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 claims description 4
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 claims description 4
- 239000003974 emollient agent Substances 0.000 claims description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims description 4
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 claims description 4
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 claims description 4
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 claims description 4
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 claims description 4
- 229960002216 methylparaben Drugs 0.000 claims description 4
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 4
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 4
- 229940068977 polysorbate 20 Drugs 0.000 claims description 4
- 239000011591 potassium Substances 0.000 claims description 4
- 229910052700 potassium Inorganic materials 0.000 claims description 4
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 claims description 4
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 claims description 4
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 claims description 4
- 239000000230 xanthan gum Substances 0.000 claims description 4
- 235000010493 xanthan gum Nutrition 0.000 claims description 4
- 229920001285 xanthan gum Polymers 0.000 claims description 4
- 229940082509 xanthan gum Drugs 0.000 claims description 4
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 claims description 3
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 claims description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims description 3
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 3
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 3
- WINXNKPZLFISPD-UHFFFAOYSA-M Saccharin sodium Chemical compound [Na+].C1=CC=C2C(=O)[N-]S(=O)(=O)C2=C1 WINXNKPZLFISPD-UHFFFAOYSA-M 0.000 claims description 3
- 235000021355 Stearic acid Nutrition 0.000 claims description 3
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 3
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 claims description 3
- 229940008099 dimethicone Drugs 0.000 claims description 3
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 3
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 3
- 150000002191 fatty alcohols Chemical class 0.000 claims description 3
- 229940075507 glyceryl monostearate Drugs 0.000 claims description 3
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 3
- 229940071826 hydroxyethyl cellulose Drugs 0.000 claims description 3
- 229940119170 jojoba wax Drugs 0.000 claims description 3
- 235000001130 magnesium glycerophosphate Nutrition 0.000 claims description 3
- 239000011742 magnesium glycerophosphate Substances 0.000 claims description 3
- BHJKUVVFSKEBEX-UHFFFAOYSA-L magnesium;2,3-dihydroxypropyl phosphate Chemical compound [Mg+2].OCC(O)COP([O-])([O-])=O BHJKUVVFSKEBEX-UHFFFAOYSA-L 0.000 claims description 3
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 claims description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 3
- 239000004006 olive oil Substances 0.000 claims description 3
- 235000008390 olive oil Nutrition 0.000 claims description 3
- 238000005498 polishing Methods 0.000 claims description 3
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 3
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 claims description 3
- 239000000377 silicon dioxide Substances 0.000 claims description 3
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 3
- 235000010234 sodium benzoate Nutrition 0.000 claims description 3
- 239000004299 sodium benzoate Substances 0.000 claims description 3
- 239000011775 sodium fluoride Substances 0.000 claims description 3
- 235000013024 sodium fluoride Nutrition 0.000 claims description 3
- 229960000414 sodium fluoride Drugs 0.000 claims description 3
- 229960004711 sodium monofluorophosphate Drugs 0.000 claims description 3
- 239000008117 stearic acid Substances 0.000 claims description 3
- 229940013618 stevioside Drugs 0.000 claims description 3
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims description 3
- 235000019202 steviosides Nutrition 0.000 claims description 3
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims description 2
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 claims description 2
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 claims description 2
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims description 2
- NKEQOUMMGPBKMM-UHFFFAOYSA-N 2-hydroxy-2-[2-(2-hydroxy-3-octadecanoyloxypropoxy)-2-oxoethyl]butanedioic acid Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CC(O)(C(O)=O)CC(O)=O NKEQOUMMGPBKMM-UHFFFAOYSA-N 0.000 claims description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 claims description 2
- 108010011485 Aspartame Proteins 0.000 claims description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 2
- 239000005973 Carvone Substances 0.000 claims description 2
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 claims description 2
- 235000005979 Citrus limon Nutrition 0.000 claims description 2
- 244000131522 Citrus pyriformis Species 0.000 claims description 2
- 241001672694 Citrus reticulata Species 0.000 claims description 2
- 240000000560 Citrus x paradisi Species 0.000 claims description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims description 2
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 claims description 2
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 claims description 2
- 244000004281 Eucalyptus maculata Species 0.000 claims description 2
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 claims description 2
- 239000005792 Geraniol Substances 0.000 claims description 2
- 229920002907 Guar gum Polymers 0.000 claims description 2
- 244000178870 Lavandula angustifolia Species 0.000 claims description 2
- 235000010663 Lavandula angustifolia Nutrition 0.000 claims description 2
- 235000014749 Mentha crispa Nutrition 0.000 claims description 2
- 244000246386 Mentha pulegium Species 0.000 claims description 2
- 235000016257 Mentha pulegium Nutrition 0.000 claims description 2
- 244000078639 Mentha spicata Species 0.000 claims description 2
- 235000004357 Mentha x piperita Nutrition 0.000 claims description 2
- 244000179970 Monarda didyma Species 0.000 claims description 2
- 235000010672 Monarda didyma Nutrition 0.000 claims description 2
- 240000009023 Myrrhis odorata Species 0.000 claims description 2
- 235000007265 Myrrhis odorata Nutrition 0.000 claims description 2
- GLZPCOQZEFWAFX-JXMROGBWSA-N Nerol Natural products CC(C)=CCC\C(C)=C\CO GLZPCOQZEFWAFX-JXMROGBWSA-N 0.000 claims description 2
- 235000021314 Palmitic acid Nutrition 0.000 claims description 2
- 235000012550 Pimpinella anisum Nutrition 0.000 claims description 2
- 239000002202 Polyethylene glycol Substances 0.000 claims description 2
- 241000220317 Rosa Species 0.000 claims description 2
- 235000019486 Sunflower oil Nutrition 0.000 claims description 2
- 244000223014 Syzygium aromaticum Species 0.000 claims description 2
- 235000016639 Syzygium aromaticum Nutrition 0.000 claims description 2
- 240000002657 Thymus vulgaris Species 0.000 claims description 2
- 235000007303 Thymus vulgaris Nutrition 0.000 claims description 2
- 235000018936 Vitellaria paradoxa Nutrition 0.000 claims description 2
- 241001135917 Vitellaria paradoxa Species 0.000 claims description 2
- FGUZFFWTBWJBIL-XWVZOOPGSA-N [(1r)-1-[(2s,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)O[C@H](CO)[C@H]1OC[C@H](O)[C@H]1O FGUZFFWTBWJBIL-XWVZOOPGSA-N 0.000 claims description 2
- 239000004480 active ingredient Substances 0.000 claims description 2
- 229940011037 anethole Drugs 0.000 claims description 2
- 239000000605 aspartame Substances 0.000 claims description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 2
- 235000010357 aspartame Nutrition 0.000 claims description 2
- 229960003438 aspartame Drugs 0.000 claims description 2
- 235000021302 avocado oil Nutrition 0.000 claims description 2
- 239000008163 avocado oil Substances 0.000 claims description 2
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 claims description 2
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 claims description 2
- 229940043256 calcium pyrophosphate Drugs 0.000 claims description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 2
- 229940105329 carboxymethylcellulose Drugs 0.000 claims description 2
- 239000004359 castor oil Substances 0.000 claims description 2
- 235000019438 castor oil Nutrition 0.000 claims description 2
- 229940093528 cetearyl ethylhexanoate Drugs 0.000 claims description 2
- 229960005233 cineole Drugs 0.000 claims description 2
- 229940043350 citral Drugs 0.000 claims description 2
- 235000000484 citronellol Nutrition 0.000 claims description 2
- 229940086555 cyclomethicone Drugs 0.000 claims description 2
- 235000019821 dicalcium diphosphate Nutrition 0.000 claims description 2
- FXNRKXSSLJKNGH-UHFFFAOYSA-L dipotassium;fluoro-dioxido-oxo-$l^{5}-phosphane Chemical compound [K+].[K+].[O-]P([O-])(F)=O FXNRKXSSLJKNGH-UHFFFAOYSA-L 0.000 claims description 2
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 claims description 2
- 229940113087 geraniol Drugs 0.000 claims description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 2
- 229930182470 glycoside Natural products 0.000 claims description 2
- 150000002338 glycosides Chemical class 0.000 claims description 2
- 239000000665 guar gum Substances 0.000 claims description 2
- 235000010417 guar gum Nutrition 0.000 claims description 2
- 229960002154 guar gum Drugs 0.000 claims description 2
- 235000001050 hortel pimenta Nutrition 0.000 claims description 2
- 239000001102 lavandula vera Substances 0.000 claims description 2
- 235000018219 lavender Nutrition 0.000 claims description 2
- 235000001510 limonene Nutrition 0.000 claims description 2
- 229940087305 limonene Drugs 0.000 claims description 2
- 229940041616 menthol Drugs 0.000 claims description 2
- 229960001047 methyl salicylate Drugs 0.000 claims description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 claims description 2
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 claims description 2
- 229960005323 phenoxyethanol Drugs 0.000 claims description 2
- 229920001223 polyethylene glycol Polymers 0.000 claims description 2
- 229920000193 polymethacrylate Polymers 0.000 claims description 2
- 235000003270 potassium fluoride Nutrition 0.000 claims description 2
- 239000011698 potassium fluoride Substances 0.000 claims description 2
- 239000004302 potassium sorbate Substances 0.000 claims description 2
- 235000010241 potassium sorbate Nutrition 0.000 claims description 2
- 229940069338 potassium sorbate Drugs 0.000 claims description 2
- RMGVATURDVPNOZ-UHFFFAOYSA-M potassium;hexadecyl hydrogen phosphate Chemical compound [K+].CCCCCCCCCCCCCCCCOP(O)([O-])=O RMGVATURDVPNOZ-UHFFFAOYSA-M 0.000 claims description 2
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 claims description 2
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 claims description 2
- 229960003415 propylparaben Drugs 0.000 claims description 2
- 235000002020 sage Nutrition 0.000 claims description 2
- 229940057910 shea butter Drugs 0.000 claims description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 2
- 229940079862 sodium lauryl sarcosinate Drugs 0.000 claims description 2
- 159000000000 sodium salts Chemical class 0.000 claims description 2
- WRZYGPIFICWRCG-OOFFSTKBSA-M sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4s,5s,6s)-2-[[(3s,4ar,6ar,6bs,8as,11s,12ar,14ar,14bs)-11-carboxylato-4,4,6a,6b,8a,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1h-picen-3-yl]oxy]-6-carboxylato-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trih Chemical compound [Na+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O WRZYGPIFICWRCG-OOFFSTKBSA-M 0.000 claims description 2
- ADWNFGORSPBALY-UHFFFAOYSA-M sodium;2-[dodecyl(methyl)amino]acetate Chemical compound [Na+].CCCCCCCCCCCCN(C)CC([O-])=O ADWNFGORSPBALY-UHFFFAOYSA-M 0.000 claims description 2
- 229940057429 sorbitan isostearate Drugs 0.000 claims description 2
- 239000002600 sunflower oil Substances 0.000 claims description 2
- 239000001585 thymus vulgaris Substances 0.000 claims description 2
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 claims description 2
- 239000000341 volatile oil Substances 0.000 claims description 2
- 239000010497 wheat germ oil Substances 0.000 claims description 2
- OCUCCJIRFHNWBP-IYEMJOQQSA-L Copper gluconate Chemical compound [Cu+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OCUCCJIRFHNWBP-IYEMJOQQSA-L 0.000 claims 1
- 102000007327 Protamines Human genes 0.000 claims 1
- 108010007568 Protamines Proteins 0.000 claims 1
- 229940081733 cetearyl alcohol Drugs 0.000 claims 1
- 229940108925 copper gluconate Drugs 0.000 claims 1
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims 1
- 229960003975 potassium Drugs 0.000 claims 1
- 235000007686 potassium Nutrition 0.000 claims 1
- 229940048914 protamine Drugs 0.000 claims 1
- 238000009736 wetting Methods 0.000 claims 1
- 239000000499 gel Substances 0.000 description 20
- 239000000243 solution Substances 0.000 description 16
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 12
- 230000000069 prophylactic effect Effects 0.000 description 11
- 238000003756 stirring Methods 0.000 description 10
- 229940095731 candida albicans Drugs 0.000 description 9
- 235000010443 alginic acid Nutrition 0.000 description 8
- 229920000615 alginic acid Polymers 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 7
- 229940072056 alginate Drugs 0.000 description 7
- 239000002552 dosage form Substances 0.000 description 6
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 5
- 239000003242 anti bacterial agent Substances 0.000 description 5
- 229940088710 antibiotic agent Drugs 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 229960003260 chlorhexidine Drugs 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 239000005414 inactive ingredient Substances 0.000 description 5
- 210000000214 mouth Anatomy 0.000 description 5
- 229940079593 drug Drugs 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 210000002950 fibroblast Anatomy 0.000 description 4
- 239000002356 single layer Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- 208000031888 Mycoses Diseases 0.000 description 3
- -1 caprylic acid triglycerides Chemical class 0.000 description 3
- 238000002512 chemotherapy Methods 0.000 description 3
- 239000008240 homogeneous mixture Substances 0.000 description 3
- 238000001794 hormone therapy Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 230000000699 topical effect Effects 0.000 description 3
- 208000035473 Communicable disease Diseases 0.000 description 2
- 206010017533 Fungal infection Diseases 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 208000002720 Malnutrition Diseases 0.000 description 2
- BYBLEWFAAKGYCD-UHFFFAOYSA-N Miconazole Chemical compound ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 BYBLEWFAAKGYCD-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000005757 colony formation Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 208000014951 hematologic disease Diseases 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000002458 infectious effect Effects 0.000 description 2
- 208000027866 inflammatory disease Diseases 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 229960002509 miconazole Drugs 0.000 description 2
- 230000002906 microbiologic effect Effects 0.000 description 2
- 244000005706 microflora Species 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 229940051866 mouthwash Drugs 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 150000002960 penicillins Chemical class 0.000 description 2
- 229940068196 placebo Drugs 0.000 description 2
- 239000000902 placebo Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 229960002920 sorbitol Drugs 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 208000030507 AIDS Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 208000002064 Dental Plaque Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 208000031886 HIV Infections Diseases 0.000 description 1
- 208000037357 HIV infectious disease Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000736262 Microbiota Species 0.000 description 1
- 206010028080 Mucocutaneous candidiasis Diseases 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- 206010061308 Neonatal infection Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000025845 adhesion to host Effects 0.000 description 1
- 239000000783 alginic acid Chemical class 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001032 anti-candidal effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229960004022 clotrimazole Drugs 0.000 description 1
- VNFPBHJOKIVQEB-UHFFFAOYSA-N clotrimazole Chemical compound ClC1=CC=CC=C1C(N1C=NC=C1)(C=1C=CC=CC=1)C1=CC=CC=C1 VNFPBHJOKIVQEB-UHFFFAOYSA-N 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 231100000676 disease causative agent Toxicity 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 230000005745 host immune response Effects 0.000 description 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 239000002955 immunomodulating agent Substances 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 238000011005 laboratory method Methods 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000005976 liver dysfunction Effects 0.000 description 1
- 238000011866 long-term treatment Methods 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000009629 microbiological culture Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 235000018343 nutrient deficiency Nutrition 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 229960000988 nystatin Drugs 0.000 description 1
- VQOXZBDYSJBXMA-NQTDYLQESA-N nystatin A1 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 VQOXZBDYSJBXMA-NQTDYLQESA-N 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000011022 opal Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 208000028169 periodontal disease Diseases 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 230000007505 plaque formation Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 102220042337 rs199607550 Human genes 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 231100000046 skin rash Toxicity 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 229960004274 stearic acid Drugs 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000007923 virulence factor Effects 0.000 description 1
- 239000000304 virulence factor Substances 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/733—Alginic acid; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Birds (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Description
重量パーセントで活性薬剤、すなわち、
0.3〜20.0重量%の量のキシリトール、
0.01〜2.0重量%の量のアルギン酸ナトリウム、又はアルギン酸カリウム、又はそれらの混合物、と共に
不活性成分、
を含む。
湿潤成分5〜70
ゲル成分0.5〜3.0
界面活性物質0.3〜3.0
香料0.05〜0.3
保存剤0.01〜0.5
水、100残分、
を含む。
研磨成分10〜30
湿潤成分5〜70
ゲル成分0.5〜3.0
虫歯予防成分0.1〜2.5
界面活性物質0.5〜3.0
香料0.3〜2.0
甘味料0.01〜0.3
水、100残分、
を含む。
湿潤成分0.2〜10
界面活性物質0.5〜4.0
皮膚軟化薬0.5〜30
構造化剤(structuring agent)1.0〜3.0
香料0.01〜0.5
保存剤0.01〜0.5
水、100残分、
を含む。
湿潤成分3.0〜70
界面活性物質0.5〜3.0
香料0.01〜0.5
甘味料0.005〜0.2
保存剤0.01〜0.5
水、100残分、
を含む。
0.6〜18.0の量のキシリトール、及び
0.1〜1.6の量のアルギン酸ナトリウム、又はアルギン酸カリウム、又はそれらの混合物、
を含む。
カンジダアルビカンス(Candida albicans)は、カンジダ症の最も主要な原因病原体である(最大62%の発生率)。カンジダ症を発生する要因は、新生児又は高齢者、栄養欠乏、抗生物質、腫瘍、HIV感染、化学療法、ホルモン療法、及び義歯の装着である。疾患の顕性化は、コロニーが形成された組織の状態、カンジダの病原性因子、及び宿主免疫応答の重症度次第である。
予防組成物をゲルとして具体化できる可能性を、表1に表される実施例によって示す。ゲル製剤は、以下の態様で調製される。
予防組成物の歯磨き粉としての具体化の可能性を、表 2に示す実施例によって説明する。
液剤としての予防口腔ケア組成物の具体化の可能性を、表3に示す実施例によって説明する。
化粧エマルションクリームとしての予防組成物の具体化の可能性を、表4に示す実施例によって説明する。
カンジダ症の予防に関する予防組成物の有効性を、本発明によって調製された歯磨き粉の使用により説明する。
(a) 盲検では、単層は完全に破壊され(100%まで)、1線維芽細胞あたり20個のカンジダアルビカンス(Candida albicans)細胞を検出した。
(b) プラセボ試料では、単層は75 %まで破壊され、残渣は1線維芽細胞あたり12〜14個のカンジダアルビカンス(Candida albicans) 細胞であった。
(c) 本発明によって調製した歯磨き粉試料では、単層は10%まで破壊され、残渣は1線維芽細胞あたり4〜5個のカンジダアルビカンス(Candida albicans) 細胞であった。
Claims (16)
- カンジダ症の予防のための、活性成分としてキシリトールと、アルギン酸ナトリウム及び/又はアルギン酸カリウムを含む組成物であって、
上記組成物中のキシリトールの量が、0.3〜20.0重量%であり、
上記組成物中のアルギン酸ナトリウム、若しくはアルギン酸カリウム、又はそれらの混合物の量が、0.01〜2.0重量%の量であり、
但し、上記組成物が、プロタミン及びグルコン酸銅を含まない、組成物。 - 組成物がゲルである場合、重量パーセントで、
湿潤成分5〜70
ゲル成分0.5〜3.0
界面活性物質0.3〜3.0
香料0.05〜0.3
保存剤0.01〜0.5
水、100残分
をさらに含む、請求項1に記載の組成物。 - 組成物が歯磨き粉の場合、重量パーセントで、
研磨成分10〜30
湿潤成分5〜70
ゲル成分0.5〜3.0
虫歯予防成分0.1〜2.5
界面活性物質0.5〜3.0
香料0.3〜2.0
甘味料0.01〜0.3
水、100残分、
をさらに含む、請求項1に記載の組成物。 - 組成物が化粧エマルションクリームの場合、組成物が、重量パーセントで、
湿潤成分0.2〜10
界面活性物質0.5〜4.0
皮膚軟化薬0.5〜30
構造化剤(structuring agent)1.0〜3.0
香料0.01〜0.5
保存剤0.01〜0.5
水、100残分
をさらに含む、請求項1に記載の組成物。 - 組成物が液剤である場合、組成物が、重量パーセントで、
湿潤成分3.0〜70
界面活性物質0.5〜3.0
香料0.01〜0.5
甘味料0.005〜0.2
保存剤0.01〜0.5
水、100残分、
をさらに含む、請求項1に記載の組成物。 - 前記組成物中のキシリトールの量が、0.6〜18.0重量%であり、
組成物中のアルギン酸ナトリウム、又はアルギン酸カリウム、又はそれらの混合物の量が、0.1〜1.6重量%である、請求項1〜5のいずれか1項に記載の組成物。 - 湿潤成分が、ソルビトール、グリセロール、ポリエチレングリコール、及びプロピレングリコール、から成る群から選択される1種又は2種以上の物質である、請求項2〜5のいずれか1項に記載の組成物。
- 研磨成分が、シリカ、ポリメタクリレート、ピロリン酸カルシウム、及び炭酸水素ナトリウム、から成る群から選択される1種又は2種以上の物質である、請求項3に記載の組成物。
- ゲル成分が、ヒドロキシエチルセルロース、キサンタンゴム、グアーガム、及びカルボキシメチルセルロース、から成る群から選択される1種又は2種以上の物質である、請求項2又は3に記載の組成物。
- 界面活性物質が、ラウリル硫酸ナトリウム、ラウリルサルコシン酸ナトリウム、クエン酸ステアリン酸グリセリル、クエン酸オレイン酸グリセリル、セチルリン酸カリウム、セテアリルアルコール、モノステアリン酸グリセリル、水素化ヒマシ油、ポリソルベート20、セテアリルグリコシド、イソステアリン酸ソルビタン、及びアルキルアミドベタイン、から成る群から選択される1種又は2種以上の物質である、請求項2〜5のいずれか1項に記載の組成物。
- 皮膚軟化薬が、カプリル酸トリグリセリド、ミリスチン酸イソプロピル、エチルヘキサン酸セテアリル、オリーブ油、アボカド油、ホホバ油、シアバター、コムギ胚芽油、ヒマワリ油、ジメチコン、及びシクロメチコン、から成る群から選択される1種又は2種以上の物質である、請求項4に記載の組成物。
- 構造化剤が、C14〜16脂肪アルコール、ステアリン酸、及びパルミチン酸、から成る群から選択される1種又は2種以上の物質である、請求項4に記載の組成物。
- 虫歯予防成分が、フッ化ナトリウム、フッ化カリウム、モノフルオロリン酸ナトリウム、モノフルオロリン酸カリウム、及びグリセロリン酸マグネシウム、から成る群から選択される1種又は2種以上の物質である、請求項3に記載の組成物。
- 香料が、ペパーミント、スペアミント、セージ、ユーカリ、タイム、クローブ、イチャクソウ、アニス、オレンジ、マンダリン、グレープフルーツ、レモン、ベルガモット、ネロリ、ラベンダー、及びバラ由来のエッセンシャルオイル、及び
メントール、カルボン、アネトール、ユーカリプトール、サリチル酸メチル、フェノキシエタノール、シトロネロール、ゲラニオール、ネロール、リモネン、及びシトラール、から成る群から選択される1種又は2種以上の物質である、請求項2〜5のいずれか1項に記載の組成物。 - 甘味料が、サッカリン酸ナトリウム、アスパルテームカリウム、ステビオシド、及びグリチルリチン酸カリウム又はナトリウム、から成る群から選択される1種又は2種以上の物質である、請求項3又は5に記載の組成物。
- 保存剤が、メチルパラベン、プロピルパラベン、又はそれらのナトリウム塩、安息香酸ナトリウム、及びソルビン酸カリウム、から成る群から選択される1種又は2種以上の物質である、請求項2、4又は5のいずれか1項に記載の組成物。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EA201001053A EA201001053A1 (ru) | 2010-07-08 | 2010-07-08 | Состав для профилактики кандидозов |
EA201001053 | 2010-07-08 | ||
PCT/RU2011/000407 WO2012005622A1 (ru) | 2010-07-08 | 2011-06-09 | Состав для профилактики кандидозов |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2013530221A JP2013530221A (ja) | 2013-07-25 |
JP5932786B2 true JP5932786B2 (ja) | 2016-06-08 |
Family
ID=44925755
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2013518309A Active JP5932786B2 (ja) | 2010-07-08 | 2011-06-09 | カンジダ症の予防のための組成物 |
Country Status (17)
Country | Link |
---|---|
US (2) | US20130039866A1 (ja) |
EP (1) | EP2545899B1 (ja) |
JP (1) | JP5932786B2 (ja) |
CN (2) | CN102858311A (ja) |
CY (1) | CY1122427T1 (ja) |
DK (1) | DK2545899T3 (ja) |
EA (1) | EA201001053A1 (ja) |
ES (1) | ES2766377T3 (ja) |
HR (1) | HRP20192300T1 (ja) |
HU (1) | HUE048512T2 (ja) |
LT (1) | LT2545899T (ja) |
PL (1) | PL2545899T3 (ja) |
PT (1) | PT2545899T (ja) |
RS (1) | RS59656B1 (ja) |
SI (1) | SI2545899T1 (ja) |
UA (1) | UA107487C2 (ja) |
WO (1) | WO2012005622A1 (ja) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104955462A (zh) * | 2012-11-26 | 2015-09-30 | 阿波罗尼亚保健股份有限公司 | 用于治疗或预防龋齿的组合物、用途和方法 |
RU2014105805A (ru) * | 2013-06-07 | 2015-08-27 | Валерий Валентинович Правдин | Многофункциональная зубная паста |
CA2920110C (en) | 2013-08-08 | 2022-05-31 | Novan, Inc. | Compositions and kits including a nitric oxide releasing compound and a hydrogel |
US10322082B2 (en) | 2014-07-11 | 2019-06-18 | Novan, Inc. | Topical antiviral compositions and methods of using the same |
CN104434686A (zh) * | 2014-12-10 | 2015-03-25 | 唯美度科技(北京)有限公司 | 一种含红加仑提取物眼霜及其制备方法 |
WO2018203327A1 (en) * | 2017-04-30 | 2018-11-08 | Resdevco Research And Development Co. Ltd. | Composition containing phenethyl alcohol for treatment of candida infection |
EP3698769B1 (en) * | 2019-02-22 | 2023-06-07 | Steven De Mars | An oral remineralization accelerating composition |
MX2021011355A (es) * | 2019-03-18 | 2021-10-13 | Sunstar Americas Inc | Composicion para cuidado oral. |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0199806A4 (en) * | 1984-11-08 | 1988-06-13 | Zetachron Inc | TOOTHPASTE CONTAINING ALGINATE CALCIUM CHELATING AGENT. |
JPH0655659B2 (ja) * | 1985-04-10 | 1994-07-27 | ライオン株式会社 | 練歯磨の製造方法 |
US4775525A (en) * | 1985-12-16 | 1988-10-04 | Ivo Pera | Oral hygiene formulation containing sodium alginate |
GB9212706D0 (en) * | 1992-06-16 | 1992-07-29 | Smithkline Beecham Plc | Novel composition |
PL173704B1 (pl) * | 1992-10-28 | 1998-04-30 | Den Mat Corp | Bezalkoholowa, przeciwbakteryjna kompozycja do higieny jamy ustnej |
GB9402877D0 (en) | 1994-02-15 | 1994-04-06 | Torchinsky Alick | Mouthwash |
US5695746A (en) * | 1995-07-28 | 1997-12-09 | Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. | Liquid dentifrice with mouthwash fresh taste |
WO1998011867A1 (en) * | 1996-09-20 | 1998-03-26 | Warner-Lambert Company | Oral compositions containing a zinc compound |
EP0979091A1 (en) * | 1997-04-30 | 2000-02-16 | Reckitt Benckiser Healthcare (UK) Limited | Pourable alginate compositions |
ES2132033B1 (es) * | 1997-11-06 | 2000-03-01 | Dentaid Sa | Composicion oral para el tratamiento de la halitosis. |
FI974385A0 (fi) * | 1997-12-01 | 1997-12-01 | Xyrofin Oy | Anvaendning av xylitol foer bekaempning av jaestinfektion och xylitolpreparat foer denna anvaendning |
JP2000333973A (ja) * | 1999-05-28 | 2000-12-05 | Lion Corp | キシリトールを含有する義歯安定剤 |
DE19941933A1 (de) * | 1999-09-03 | 2001-03-15 | Cognis Deutschland Gmbh | Tensidsysteme |
US6531141B1 (en) * | 2000-03-07 | 2003-03-11 | Ortho-Mcneil Pharmaceutical, Inc. | Oil-in-water emulsion containing tretinoin |
KR100537834B1 (ko) * | 2000-12-21 | 2005-12-19 | 주식회사 엘지생활건강 | 목단피 추출물을 유효성분으로 함유하는 구취 억제용 구강 조성물 |
NL1018421C1 (nl) * | 2001-06-29 | 2003-01-07 | Sara Lee De Nv | Mondverzorgingsmiddel. |
JP2003081795A (ja) * | 2001-09-17 | 2003-03-19 | Lion Corp | 歯磨組成物 |
EP1297821A1 (en) * | 2001-10-01 | 2003-04-02 | Hive of Beauty (Europe) BVBA | Skin treatment compositions |
US20040057908A1 (en) * | 2001-12-13 | 2004-03-25 | Bowen William H. | Oral compositions and use thereof |
CN1433752A (zh) * | 2002-01-21 | 2003-08-06 | 权力敏 | 海洋生物素净足液 |
JP2004269437A (ja) * | 2003-03-10 | 2004-09-30 | Nissen Techno:Kk | 歯磨き剤 |
CA2526626C (en) * | 2003-05-29 | 2012-08-28 | Sun Pharmaceuticals Corporation | Emulsion base for skin care compositions |
US8524198B2 (en) * | 2003-06-20 | 2013-09-03 | Donald W. Bailey | Xylitol dental maintenance system |
WO2005016307A1 (en) * | 2003-07-30 | 2005-02-24 | Stiefel Laboratories, Inc. | Steroidal compositions containing hydroxycarboxylic acids and methods of using the same |
JP2005187333A (ja) * | 2003-12-24 | 2005-07-14 | Lion Corp | う蝕予防用塗布剤組成物 |
EP1776083A4 (en) * | 2004-07-02 | 2010-06-02 | Discus Dental Llc | SENSITIVITY-RELATED TOOTH COMPOSITIONS |
US8858920B2 (en) * | 2004-12-21 | 2014-10-14 | Colgate-Palmolive Company | Anti-caries oral care composition with xylitol |
JP2008303188A (ja) * | 2007-06-08 | 2008-12-18 | Univ Of Tokushima | カンジダバイオフィルム除去剤 |
JP4919060B2 (ja) * | 2007-06-28 | 2012-04-18 | ライオン株式会社 | 口腔用組成物及びアルジンジパイン阻害剤 |
US8828363B2 (en) * | 2007-08-03 | 2014-09-09 | Gary H. EIREW | Pharmaceutical composition for improving oral hygiene and methods thereof |
-
2010
- 2010-07-08 EA EA201001053A patent/EA201001053A1/ru unknown
-
2011
- 2011-06-09 WO PCT/RU2011/000407 patent/WO2012005622A1/ru active Application Filing
- 2011-06-09 US US13/635,909 patent/US20130039866A1/en not_active Abandoned
- 2011-06-09 ES ES11803866T patent/ES2766377T3/es active Active
- 2011-06-09 DK DK11803866.0T patent/DK2545899T3/da active
- 2011-06-09 LT LTEP11803866.0T patent/LT2545899T/lt unknown
- 2011-06-09 UA UAA201212076A patent/UA107487C2/uk unknown
- 2011-06-09 CN CN2011800204075A patent/CN102858311A/zh active Pending
- 2011-06-09 HU HUE11803866A patent/HUE048512T2/hu unknown
- 2011-06-09 JP JP2013518309A patent/JP5932786B2/ja active Active
- 2011-06-09 PT PT118038660T patent/PT2545899T/pt unknown
- 2011-06-09 SI SI201131823T patent/SI2545899T1/sl unknown
- 2011-06-09 CN CN201410568964.6A patent/CN104274339A/zh active Pending
- 2011-06-09 RS RS20191607A patent/RS59656B1/sr unknown
- 2011-06-09 PL PL11803866T patent/PL2545899T3/pl unknown
- 2011-06-09 EP EP11803866.0A patent/EP2545899B1/en active Active
-
2015
- 2015-06-03 US US14/729,463 patent/US9597276B2/en active Active
-
2019
- 2019-12-18 CY CY20191101331T patent/CY1122427T1/el unknown
- 2019-12-20 HR HRP20192300TT patent/HRP20192300T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
RS59656B1 (sr) | 2020-01-31 |
PT2545899T (pt) | 2019-12-18 |
LT2545899T (lt) | 2020-01-27 |
HRP20192300T1 (hr) | 2020-03-06 |
EP2545899B1 (en) | 2019-11-27 |
ES2766377T3 (es) | 2020-06-12 |
CN104274339A (zh) | 2015-01-14 |
EA015747B1 (ru) | 2011-10-31 |
UA107487C2 (uk) | 2015-01-12 |
HUE048512T2 (hu) | 2020-08-28 |
US20150265517A1 (en) | 2015-09-24 |
EP2545899A4 (en) | 2015-11-04 |
EA201001053A1 (ru) | 2011-10-31 |
US9597276B2 (en) | 2017-03-21 |
DK2545899T3 (da) | 2020-01-27 |
JP2013530221A (ja) | 2013-07-25 |
PL2545899T3 (pl) | 2020-05-18 |
WO2012005622A1 (ru) | 2012-01-12 |
EP2545899A1 (en) | 2013-01-16 |
CY1122427T1 (el) | 2021-01-27 |
US20130039866A1 (en) | 2013-02-14 |
CN102858311A (zh) | 2013-01-02 |
SI2545899T1 (sl) | 2020-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5932786B2 (ja) | カンジダ症の予防のための組成物 | |
RU2640184C2 (ru) | Безводные порошкообразные и жидкие частицы | |
RU2683779C2 (ru) | Композиции и способы повышения эффективности местного нанесения кислотного полезного агента | |
RU2722783C2 (ru) | Композиции и способы повышения эффективности местного нанесения щелочного полезного агента | |
RU2699560C1 (ru) | Стоматологический гель с фитопелоидной композицией | |
US20120288451A1 (en) | Means for removing tobacco tars and composition containing same | |
CN108042420B (zh) | 一种用于口腔保健的组合物及其应用 | |
JP5730025B2 (ja) | 口腔用組成物 | |
EA012247B1 (ru) | Лечебно-профилактический состав для ухода за полостью рта | |
CN104606085B (zh) | 一种抗菌的醋酸洗必泰纳米乳漱口液及其制备方法 | |
JP2015189708A (ja) | オーラルケア組成物 | |
JP6065229B2 (ja) | 口腔機能の改善または向上剤、およびそれを含有する口腔用の医薬品、医薬部外品、化粧品または飲食品 | |
WO2017018906A1 (ru) | Лечебно-профилактический ополаскиватель для десен | |
EP2630944A1 (en) | Silicon-based particle composition | |
EP2906179B1 (en) | Topical ubiquinol oral supplement compositions with amorphous calcium phosphate | |
JP5631175B2 (ja) | 口腔用組成物 | |
KR20210088589A (ko) | 구강 점막 담체 및 보호제 | |
JP5274826B2 (ja) | 口腔用組成物 | |
JP3140412B2 (ja) | 牛膝または楡白皮抽出物を含有する口腔用組成物 | |
JP7330692B2 (ja) | 口腔用組成物 | |
JP2003212743A (ja) | 知覚過敏症用口腔用組成物 | |
WO2006110183A2 (en) | Dental formulation | |
JP2006282554A (ja) | エッセンス剤形の皮膚外用剤 | |
Abedi et al. | Nanotechnology in toothpaste: Fundamentals, trends, and safety | |
JP2023177682A (ja) | プラーク形成抑制用組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20130620 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140401 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20140630 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20140707 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140908 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20150324 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20150624 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150813 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20160202 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160219 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20160329 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20160428 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5932786 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |